our flow cytometric data suggest that prostatic comedocarcinoma represents a potentially aggressive tumor demonstrating cytogenetic aberration shown to be associated with poor clinical outcome in prostatic adenocarcinoma .
C0033572
prostatic
C0007112
prostatic adenocarcinoma